J Korean Ophthalmol Soc.  2013 Jul;54(7):1114-1118. 10.3341/jkos.2013.54.7.1114.

A Case of Angiosarcoma Arising from the Eyelid

• Yoo GY
• Jung SK
• Paik JS
• Yang SW

• KMID: 2217425
• DOI: http://doi.org/10.3341/jkos.2013.54.7.1114

Abstract

PURPOSE
To report a case of angiosarcoma arising from the eyelid.
CASE SUMMARY
A 72-year-old male patient presented with swelling and erythema on the upper and lower eyelid of 10 months in duration. After the diagnosis of cutaneous angiosarcoma via tissue biopsy, no evidence of systemic metastasis was found. The right eyelid was treated with radiation therapy and a partial clinical response was achieved. After 4 months of follow-up, swelling and a red-purple plaque developed on the same (right) eyelid. Another biopsy was performed and the histological examination indicated a recurrence of angiosarcoma. Neither local nor distant metastases were observed. However, large-sized and ill-defined margins warranted size reduction by paclitaxel neoadjuvant chemotherapy, followed by surgical excision and eyelid reconstruction.
CONCLUSIONS
Angiosarcoma commonly occurs on the face and scalp, but rarely occurs on the eyelids. Herein, the authors report a case of angiosarcoma arising from the eyelid.

Keyword

Angiosarcoma; Eyelid; Recurrent angiosarcoma

MeSH Terms

Biopsy
Erythema
Eyelids
Follow-Up Studies
Hemangiosarcoma
Humans
Male
Neoplasm Metastasis
Paclitaxel
Recurrence
Scalp
Paclitaxel

Figure

• 

  Figure 1. (A) This photograph shows erythematous swelling on the right upper and lower eyelid. (B) At 4 months after radiation therapy, newly developed angiosarcoma of his right upper eyelid is observed.

• 

  Figure 2. (A) Irregular vascular proliferation is shown in subepithelial area of the specimen obtained from the patient (H&E, ×100).(B) Cytological atypia is seen under high power (H&E, ×400). (C, D) Atypical endothelial cells shows immunostain for CD31 (C: ×400) and CD32 (D: ×400).

• 

  Figure 3. (A) The lesion of angiosarcoma was removed widely, including surrounding normal skin and connective tissue. During the surgery, the tumor was completely removed by performing frozen section biopsy of the lesion and its surrounding area under the local anesthesia. (B) Skin graft using the left upper eyelid was performed.

• 

  Figure 4. After 6 months, a postoperative photograph shows healthy grafted skin and no recurrence of the tumor in the right upper eyelid.

Reference

References

1. Enzinger FM, Weiss SW. Soft tissue tumors, 2nd ed. St. Louis:: CV Mosby;1988. p. 545–78.

2. Maddox JC, Evans HL. Angiosarcoma of skin and soft tissue: a study of forty-four cases. Cancer. 1981; 48:1907–21.

3. Caro MR, Stubenrauch CH Jr. Hemangioendothelioma of the skin. Arch Derm Syphilol. 1945; 51:295–304.

4. Papalas JA, Manavi CK, Woodward JA, et al. Angiosarcoma of the eyelid: a clinicopathologic comparison between isolated unilateral tumors and tumors demonstrating extrapalpebral involvement. Am J Dermatopathol. 2010; 32:694–9.

5. de Keizer RJ, de Wolff-Rouendaal D, Nooy MA. Angiosarcoma of the eyelid and periorbital region. Experience in Leiden with iri-dium192 brachytherapy and low-dose doxorubicin chemotherapy. Orbit. 2008; 27:5–12.

6. DeMartelaere SL, Roberts D, Burgess MA, et al. Neoadjuvant che-motherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement. Head Neck. 2008; 30:639–46.

7. Tay YK, Ong BH. Cutaneous angiosarcoma presenting as recurrent angio-oedema of the face. Br J Dermatol. 2000; 143:1346–8.

8. Conway RM, Hammer T, Viestenz A, et al. Cutaneous angiosarco-ma of the eyelids. Br J Ophthalmol. 2003; 87:514–5.

9. Gündüz K, Shields JA, Shields CL, et al. Cutaneous angiosarcoma with eyelid involvement. Am J Ophthalmol. 1998; 125:870–1.

10. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987; 59:1046–57.

11. Jones EW. Malignant angioendothelioma of the skin. Br J Dermatol. 1964; 76:21–39.

12. Aust MR, Olsen KD, Lewis JE, et al. Angiosarcomas of the head and neck: clinical and pathologic characteristics. Ann Otol Rhinol Laryngol. 1997; 106:943–51.

13. Hiemstra CA, Mooy C, Paridaens D. Excisional surgery of peri-ocular angiosarcoma. Eye (Lond). 2004; 18:738–9.

14. Rosen A, Thimon S, Ternant D, et al. Partial response to bev-acizumab of an extensive cutaneous angiosarcoma of the face. Br J Dermatol. 2010; 163:225–7.

15. Maki RG, D'Adamo DR, Keohan ML, et al. Phase II study of sor-afenib in patients with metastatic or recurrent sarcomas. J Clin Oncol. 2009; 27:3133–40.